Komori
Pharma Foods International (2929) · InitiativeAdvancedLatest Revision of earnings forecasts (2026-09-11): "Restated"

Expansion of domestic and overseas sales of functional materials and products through a capital and business alliance with ITOCHU Corporation

First written in FY2024. 1 of 3 entries say "Advanced", first in FY2025-H1. Latest entry: 2026-09-11.

3entries
3years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024AdvancedFY2025-H12024: 120242025: 120252026: 12026
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. 2026-09-11RestatedRevision of earnings forecasts

    「Going forward, we will use the network of ITOCHU Corporation, with which we have entered into a capital and business alliance agreement, to develop domestic and overseas sales channels not only for our functional ingredients but also for functional products.」

    The company reaffirmed its policy of developing domestic and overseas sales channels for functional ingredients and products through ITOCHU Corporation's network.
  2. FY2025-H1AdvancedAnnual report

    「To further expand these sales channels, in October 2024 we entered into a capital and business alliance agreement with ITOCHU Corporation. Through the network of ITOCHU Corporation, we will sell our functional materials and functional products in domestic and overseas markets.」

    Following the execution of the capital and business alliance agreement with ITOCHU Corporation, the company has described as a business activity its policy of selling functional materials and functional products through ITOCHU Corporation's domestic and overseas network. The company also disposed of 872,400 treasury shares through a third-party allotment.
  3. FY2024First statedAnnual report

    「ITOCHU Corporation will sell functional materials and functional products developed and manufactured by the Group in domestic and overseas markets through its network.」

    On 22 October 2024, the company entered into a capital and business alliance agreement with ITOCHU Corporation to promote the domestic and overseas sale of functional materials and functional products, as well as the sharing of personnel and expertise. Through a third-party allotment, 872,400 shares, representing 3.00% of the total number of issued shares, will be allotted, with the payment date set for 6 November 2024.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Pharma Foods International yet. It last moved in the Revision of earnings forecasts of 2026-09-11: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of domestic and overseas sales of functional materials and products through a capital and business alliance with ITOCHU Corporation | Pharma Foods International Co.,Ltd. (2929) | Komori